Ginkgo biloba extract protects early brain injury after subarachnoid hemorrhage via inhibiting thioredoxin interacting protein/NLRP3 signaling pathway

Document Type : Original Article


1 Neurosurgery Department, Zhangqiu District People’s Hospital, Jinan 250200, China

2 Cardiothoracic Surgery Department, Zhangqiu District People’s Hospital, Jinan250200, China

3 Pharmacy Intravenous Admixture Services, Zhangqiu District People’s Hospital, Jinan 250200, China

4 ENT Department, Zhangqiu District People’s Hospital, Jinan 250200, China

5 Neurosurgery Department, Qilu Hospital of Shandong University, Jinan 250012, China


Objective(s): To investigate the effect of Ginkgo biloba extract EGb761 in early brain injury (EBI) after subarachnoid hemorrhage (SAH) and its mechanism.
Materials and Methods: The SAH rat model was constructed and pre-treated with EGb761.The neurological function, severity of SAH, water content of brain tissue, damage degree of the blood-brain barrier, related indexes of oxidative stress, and the level of inflammatory cytokines were compared among the groups. The expression of TXNIP/NLRP3 signaling pathway-related proteins in brain tissues was detected by Western blot.
Results: After SAH modeling, the neurological function score was significantly reduced, the degree of brain injury, levels of oxidative stress, inflammatory factors, expression of NLRP3 and TXNIP were all increased. Compared with the SAH rats, the neurological function score of rats pre-treated by EGb761 was higher, the degree of brain injury, levels of oxidative stress and inflammatory factors, expression of NLRP3 and TXNIP were all lower.
Conclusion: EGb761 could protect neurological injury after SAH and its mechanism may be that EGb761 could inhibit the activation of the TXNIP/NLRP3 signaling pathway and inflammatory reaction after oxidative stress.


1. Lucke-Wold BP, Logsdon AF, Manoranjan B, Turner RC, McConnell E, Vates GE et al. Aneurysmal subarachnoid hemorrhage and neuroinflammation: A comprehensive review. Int J Mol Sci 2016;17:497-513.
2. Cahill J, Zhang JH. Subarachnoid hemorrhage: is it time for a new direction? Stroke 2009;40(3 Suppl):S86-87.
3. Fujii M, Yan J, Rolland WB, Soejima Y, Caner B, Zhang JH. Early brain injury, an evolving frontier in subarachnoid hemorrhage research. Transl Stroke Res 2013;4:432-446.
4. Tian J, Liu Y, Chen K. Ginkgo biloba Extract in vascular protection: molecular mechanisms and clinical applications. Curr Vasc Pharmacol 2017;15:532-548.
5. Savaskan E, Mueller H, Hoerr R, von Gunten A, Gauthier S. Treatment effects of Ginkgo biloba extract EGb 761(R) on the spectrum of behavioral and psychological symptoms of dementia: meta-analysis of randomized controlled trials. Int Psychogeriatr 2018;30:285-293.
6. Li T, Zhang Y, Tian J, Yang L, Wang J. Ginkgo biloba pretreatment attenuates myocardial ischemia-reperfusion injury via  mitoBKCa. Am J Chin Med 2019:1-17.
7. Erbil G, Ozbal S, Sonmez U, Pekcetin C, Tugyan K, Bagriyanik A et al. Neuroprotective effects of selenium and Ginkgo biloba extract (EGb761) against ischemia and reperfusion injury in rat brain. Neurosciences (Riyadh) 2008;13:233-238.
8. Bederson JB, Germano IM, Guarino L. Cortical blood flow and cerebral perfusion pressure in a new noncraniotomy model  of subarachnoid hemorrhage in the rat. Stroke 1995;26:1086-1092.
9. Sugawara T, Ayer R, Jadhav V, Zhang JH. A new grading system evaluating bleeding scale in filament perforation subarachnoid hemorrhage rat model. J Neurosci Methods 2008;167:327-334.
10. Li Y, Xiong Y, Zhang H, Li J, Wang D, Chen W et al. Ginkgo biloba extract EGb761 attenuates brain death-induced renal injury by inhibiting pro-inflammatory cytokines and the SAPK and JAK-STAT signalings. Sci Rep 2017;7:45192.
11. Singh SK, Srivastav S, Castellani RJ, Plascencia-Villa G, Perry G. Neuroprotective and antioxidant effect of Ginkgo biloba extract against AD and other neurological disorders. Neurotherapeutics 2019;16:666-674.
12. Guan ZF, Zhang XM, Tao YH, Zhang Y, Huang YY, Chen G et al. EGb761 improves the cognitive function of elderly db/db(-/-) diabetic mice by regulating the beclin-1 and NF-kappaB signaling pathways. Metab Brain Dis 2018;33:1887-1897.
13. Sun BL, Xia ZL, Yang MF, Qiu PM. Effects of Ginkgo biloba extract on somatosensory evoked potential, nitric oxide  levels in serum and brain tissue in rats with cerebral vasospasm after subarachnoid hemorrhage. Clin Hemorheol Microcirc 2000;23:139-144.
14. Yu T, Fan Y, Xu Y, Xu L, Xu G, Cao F et al. Standardized Ginkgo biloba extract EGb 761(R) attenuates early brain injury following subarachnoid hemorrhage via suppressing neuronal apoptosis through the  activation of Akt signaling. Biomed Pharmacother 2018;107:329-337.
15. Topkoru B, Egemen E, Solaroglu I, Zhang JH. Early brain injury or vasospasm? An overview of common Mechanisms. Curr Drug Targets 2017;18:1424-1429.
16. Xie Q, Shen WW, Zhong J, Huang C, Zhang L, Li J. Lipopolysaccharide/adenosine triphosphate induces IL1beta and IL-18 secretion through the NLRP3 inflammasome in RAW264.7 murine macrophage cells. Int J Mol Med 2014;34:341-349.
17. Liu HD, Li W, Chen ZR, Hu YC, Zhang DD, Shen W et al. Expression of the NLRP3 inflammasome in cerebral cortex after traumatic brain injury in a rat model. Neuro Chem Res 2013;38:2072-2083.
18. Pan Y, Chen XY, Zhang QY, Kong LD. Microglial NLRP3 inflammasome activation mediates IL-1beta-related inflammation in prefrontal cortex of depressive rats. B rain Behav Immun 2014;41:90-100.
19. Farina C, Aloisi F, Meinl E. Astrocytes are active players in cerebral innate immunity. Trends Immunol 2007;28:138-145.
20. Chen S, Ma Q, Krafft PR, Hu Q, Rolland WN, Sherchan P et al. P2X7R/cryopyrin inflammasome axis inhibition reduces neuroinflammation after SAH. Neurobiol Dis 2013;58:296-307.
21. Tschopp J, Schroder K. NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production? Nat Rev Immunol 2010;10:210-215.
22. Iyer SS, He Q, Janczy JR, Elliott EI, Zhong Z, Olivier AK et al. Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. Immunity 2013;39:311-323.
23. Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011;469:221-225.
24. Gao P, Meng XF, Su H, He FF, Chen S, Tang H et al. Thioredoxin-interacting protein mediates NALP3 inflammasome activation in podocytes during diabetic nephropathy. Biochim Biophys Acta 2014;1843:2448-2460.